These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26204501)

  • 1. Dual ligand immunoliposomes for drug delivery to the brain.
    Loureiro JA; Gomes B; Fricker G; Cardoso I; Ribeiro CA; Gaiteiro C; Coelho MA; Pereira Mdo C; Rocha S
    Colloids Surf B Biointerfaces; 2015 Oct; 134():213-9. PubMed ID: 26204501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes functionalized to overcome the blood-brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model.
    Salvati E; Re F; Sesana S; Cambianica I; Sancini G; Masserini M; Gregori M
    Int J Nanomedicine; 2013; 8():1749-58. PubMed ID: 23674890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain drug delivery of small molecules using immunoliposomes.
    Huwyler J; Wu D; Pardridge WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14164-9. PubMed ID: 8943078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes.
    Hua S; Chang HI; Davies NM; Cabot PJ
    J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of PEGylated Immunoliposomes to Deliver Dopamine Across the Blood-Brain Barrier in a Rat Model of Parkinson's Disease.
    Kang YS; Jung HJ; Oh JS; Song DY
    CNS Neurosci Ther; 2016 Oct; 22(10):817-23. PubMed ID: 27350533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system.
    Cerletti A; Drewe J; Fricker G; Eberle AN; Huwyler J
    J Drug Target; 2000; 8(6):435-46. PubMed ID: 11328669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.
    Schnyder A; Krähenbühl S; Török M; Drewe J; Huwyler J
    Biochem J; 2004 Jan; 377(Pt 1):61-7. PubMed ID: 14516278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries.
    Hülsermann U; Hoffmann MM; Massing U; Fricker G
    J Drug Target; 2009 Sep; 17(8):610-8. PubMed ID: 19694613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).
    Jeong Lee H; Pardridge WM
    J Drug Target; 2000; 8(6):413-24. PubMed ID: 11328667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylated immunoliposomes directed against brain astrocytes.
    Chekhonin VP; Zhirkov YA; Gurina OI; Ryabukhin IA; Lebedev SV; Kashparov IA; Dmitriyeva TB
    Drug Deliv; 2005; 12(1):1-6. PubMed ID: 15801714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neuropilin 1 antibody Fab' fragment conjugated liposomal docetaxel for active targeting of tumours.
    Manjappa AS; Goel PN; Gude RP; Ramachandra Murthy RS
    J Drug Target; 2014 Sep; 22(8):698-711. PubMed ID: 24766186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
    Schnyder A; Krähenbühl S; Drewe J; Huwyler J
    J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
    Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
    Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterically stabilized anti-G(M3), anti-Le(x) immunoliposomes: targeting to B16BL6, HRT-18 cancer cells.
    Nam SM; Kim HS; Ahn WS; Park YS
    Oncol Res; 1999; 11(1):9-16. PubMed ID: 10451027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Future Sci OA; 2015 Nov; 1(4):FSO71. PubMed ID: 28031922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells.
    Sauer I; Dunay IR; Weisgraber K; Bienert M; Dathe M
    Biochemistry; 2005 Feb; 44(6):2021-9. PubMed ID: 15697227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.